Around the world there are 33.5 million patients suffering from atrial fibrillation (AF) with an
annual increase of 5 million cases. Most AF patients have an established form of an atrial …

Aims Multiple risk scores to predict ischaemic stroke (IS) in patients with atrial fibrillation (AF)
have been developed. This study aims to systematically review these scores, their …

Aims Differentiation of heart failure with reduced (HFrEF) or preserved (HFpEF) ejection
fraction independent of echocardiography is challenging in the community. Diagnostic …

Atrial fibrillation (AFib), the most prevalent arrhythmia in clinical practice, presents a growing
global health concern, particularly with the aging population, as it is associated with …

Neutrophil extracellular traps (NET) induce a procoagulant response linking inflammation
and thrombosis. Low levels of miR-146a, a brake of inflammatory response, are involved in …

Background Acute myocardial infarction (AMI) was considered to be one of the major causes
of morbidity and mortality worldwide. In order to manage the acute myocardial infarction …

The regulatory role of microRNAs (miRNAs) is mainly mediated by their effect on protein
expression and is recognized in a multitude of pathophysiological processes. In recent …

Objective—Atrial fibrillation (AF) patients experience adverse cardiovascular events (ACEs)
despite anticoagulant therapy. We reported that rs2431697 of miR-146a, a negative …

Acute ST elevation myocardial infarction (STEMI) remains a leading cause of morbidity and
mortality worldwide despite continuous advances in diagnostic, prognostic and therapeutic …

MicroRNAs (miRNAs) are a group of small single strand and noncoding RNAs that regulate
several physiological and molecular signalling pathways. Alterations of miRNA expression …